The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
The transcription factor NRF2 protects against pulmonary fibrosis
Abstract
The molecular mechanisms of pulmonary fibrosis are poorly understood, although reactive oxygen species are thought to have an important role. NRF2 is a transcription factor that protects cells and tissues from oxidative stress by activating protective antioxidant and detoxifying enzymes. We hypothesized that NRF2 protects lungs from injury and fibrosis induced by bleomycin, an anti‐neoplastic agent that causes pulmonary fibrosis in susceptible patients. To test this hypothesis, mice with targeted deletion of Nrf2 ( Nrf2 ‒/‒ ) and wild‐type ( Nrf2 +/+ ) mice were treated with bleomycin or vehicle, and pulmonary injury and fibrotic responses were compared. Bleomycin‐induced increases in lung weight, epithelial cell death, and inflammation were significantly greater in Nrf2 ‒/‒ mice than in Nrf2 +/+ mice. Indices of lung fibrosis (hydroxyproline content, collagen accumulation, fibrotic score, cell proliferation) were significantly greater in bleomycin‐treated Nrf2 ‒/‒ mice, compared with Nrf2 +/+ mice. NRF2 expression and activity were elevated in Nrf2 +/+ mice by bleomycin. Bleomycin caused greater up‐regulation of several NRF2‐inducible antioxidant enzyme genes and protein products in Nrf2 +/+ mice compared with Nrf2 ‒/‒ mice. Further, bleomycin‐induced transcripts and protein levels of lung injury and fibrosis markers were significantly attenuated in Nrf2 +/+ mice compared with Nrf2 ‒/‒ mice. Results demonstrated that NRF2 has a critical role in protection against pulmonary fibrosis, presumably through enhancement of cellular antioxidant capacity. This study has important implications for the development of intervention strategies against fibrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Itoh, K., Chiba, T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I., et al. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6943 · Cited by 3,999
Woessner, J. F. (1961) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(61)90291-0 · Cited by 3,840
Itoh, K., Wakabayashi, N., Katoh, Y., Ishii, T., Igarashi, K., Engel, J. D., & Yamamoto, M. (1999) · Genes & Development · doi:10.1101/gad.13.1.76 · Cited by 3,634 · cited 1×
“The mechanism(s) of transcriptional regulation of Nrf2 are not completely understood, though putative regulatory m echanisms of NRF2 transactivation have been suggested by Keap 1, the known cytosolic inhibitor of NRF2 (34).”
BackgroundSelf-citationDinkova-Kostova, A. T., Holtzclaw, W. D., Cole, R. N., Itoh, K., Wakabayashi, N., Katoh, Y., Yamamoto, M., & Talalay, P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172398899 · Cited by 1,947
Self-citationSimple method of estimating severity of pulmonary fibrosis on a numerical scale.
Ashcroft, T., Simpson, J. M., & Timbrell, V (1988) · Journal of Clinical Pathology · doi:10.1136/jcp.41.4.467 · Cited by 1,680
Huang, H.-C., Nguyen, T., & Pickett, C. B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206911200 · Cited by 1,034
An important function of Nrf2 in combating oxidative stress: Detoxification of acetaminophen
Chan, K., Han, X.-D., & Kan, Y. W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081082098 · Cited by 770
Enomoto, A. (2001) · Toxicological Sciences · doi:10.1093/toxsci/59.1.169 · Cited by 728
Role of NRF2 in Protection Against Hyperoxic Lung Injury in Mice
Cho, H.-Y., Jedlicka, A. E., Reddy, S. P. M., Kensler, T. W., Yamamoto, M., Zhang, L.-Y., & Kleeberger, S. R. (2002) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.26.2.4501 · Cited by 659
Self-citationZuo, F., Kaminski, N., Eugui, E., Allard, J., Yakhini, Z., Ben-Dor, A., Lollini, L., Morris, D., Kim, Y., DeLustro, B., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092134099 · Cited by 620
Kwak, M.-K., Itoh, K., Yamamoto, M., & Kensler, T. W. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.9.2883-2892.2002 · Cited by 593
Self-citationNrf2 is essential for protection against acute pulmonary injury in mice
Chan, K., & Kan, Y. W. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12731 · Cited by 574
Kaminski, N., Allard, J. D., Pittet, J. F., Zuo, F., Griffiths, M. J. D., Morris, D., Huang, X., Sheppard, D., & Heller, R. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1778 · Cited by 417
Oxidant-mediated epithelial cell injury in idiopathic pulmonary fibrosis.
Cantin, A. M., North, S. L., Fells, G. A., Hubbard, R. C., & Crystal, R. G. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113005 · Cited by 350
Accelerated DNA adduct formation in the lung of the Nrf2 knockout mouse exposed to diesel exhaust
Aoki, Y., Sato, H., Nishimura, N., Takahashi, S., Itoh, K., & Yamamoto, M. (2001) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2001.9176 · Cited by 297
Self-citationKang, K. W., Lee, S. J., Park, J. W., & Kim, S. G. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.5.1001 · Cited by 274
Matrilysin expression and function in airway epithelium.
Dunsmore, S. E., Saarialho-Kere, U. K., Roby, J. D., Wilson, C. L., Matrisian, L. M., Welgus, H. G., & Parks, W. C. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1516 · Cited by 270
Wild, A. C., & Mulcahy, R. T. (2000) · Free Radical Research · doi:10.1080/10715760000300291 · Cited by 197
Pathogenetic mechanisms in usual interstitial pneumonia/idiopathic pulmonary fibrosis
White, E. S., Lazar, M. H., & Thannickal, V. J. (2003) · The Journal of Pathology · doi:10.1002/path.1446 · Cited by 190
Gelatinase B Is Required for Alveolar Bronchiolization after Intratracheal Bleomycin
Betsuyaku, T., Fukuda, Y., Parks, W. C., Shipley, J. M., & Senior, R. M. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64563-4 · Cited by 185
Lung injury induced by butylated hydroxytoluene: cytodynamic and biochemical studies in mice.
Adamson, I. Y., Bowden, D. H., Côté, M. G., & Witschi, H. R. (1977) · PubMed · Cited by 184
Increased DNA chain breakage by combined action of bleomycin and superoxide radical
Ishida, R., & Takahashi, T. (1975) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(75)90519-7 · Cited by 183
Redox-active Protein Thioredoxin Prevents Proinflammatory Cytokine- or Bleomycin-induced Lung Injury
Hoshino, T., Nakamura, H., Okamoto, M., Kato, S., Araya, S., Nomiyama, K., Ōizumi, K., Young, H. A., Aizawa, H., & Yodoi, J. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200209-982oc · Cited by 151
IL-12 attenuates bleomycin-induced pulmonary fibrosis
Keane, M. P., Belperio, J. A., Burdick, M. D., & Strieter, R. M. (2001) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2001.281.1.l92 · Cited by 146
Role of extracellular superoxide dismutase in bleomycin-induced pulmonary fibrosis
Bowler, R. P., Nicks, M., Warnick, K., & Crapo, J. D. (2002) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00058.2001 · Cited by 140
Matrix Metalloproteinase Inhibition: From The Jurassic To The Third Millennium
Woessner, J. F. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07697.x · Cited by 134
Glutathione deficiency of the lower respiratory tract in patients with idiopathic pulmonary fibrosis
Beeh, K. M., Beier, J., Haas, I. C., Kornmann, O., Micke, P., & Buhl, R. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.00262402 · Cited by 132
Chen, E. S., Greenlee, B. M., Wills-Karp, M. A., & Möller, D. R. (2001) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.24.5.4064 · Cited by 125
Sheppard, D. (1996) · BioEssays · doi:10.1002/bies.950180809 · Cited by 117
Transforming growth factor-β: A mediator of cell regulation in acute respiratory distress syndrome
Dhainaut, J.-F., Charpentier, J., & Chiche, J. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000057901.92381.75 · Cited by 112
Sekhar, K. R., Crooks, P. A., Sonar, V. N., Friedman, D. B., Chan, J. Y., Meredith, M. J., Starnes, J. H., Kelton, K. R., Summar, S. R., Sasi, S., et al. (2003) · PubMed · Cited by 105
Arras, M., Huaux, F., Vink, A., Delos, M., Coutelier, J., Many, M., Barbarin, V., Renauld, J., & Lison, D. (2001) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.24.4.4249 · Cited by 102
Liu, J., Sime, P. J., Wu, T., Warshamana, G. S., Pociask, D. A., Tsai, S.-Y., & Brody, A. R. (2001) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.25.1.4481 · Cited by 83
Büttner, C., Skupin, A., & Rieber, E. P. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10395 · Cited by 80
Role of polymorphonuclear leukocytes in silica-induced pulmonary fibrosis.
Adamson, I. Y. R., & Bowden, D. H. (1984) · PubMed · Cited by 76
Role of MMP-2 in Alveolar Epithelial Cell Repair after Bleomycin Administration in Rabbits
Kunugi, S., Fukuda, Y., Ishizaki, M., & Yamanaka, N. (2001) · Laboratory Investigation · doi:10.1038/labinvest.3780344 · Cited by 57
Chang, M., Burgess, J. R., Scholz, R. W., & Reddy, C. C. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39376-7 · Cited by 52
DNA Strand Scission by Activated Bleomycin Group Antibiotics
Hecht, S. M. (1987) · Springer eBooks · doi:10.1007/978-1-4615-6462-1_65 · Cited by 40
Expression of thioredoxin in bleomycin-injured airway epithelium
Gon, Y., Sasada, T., Matsui, M., Hashimoto, S., Takagi, Y., Iwata, S., Wada, H., Horie, T., & Yodoi, J. (2001) · Life Sciences · doi:10.1016/s0024-3205(01)00980-8 · Cited by 34
Selman, M., Montaño, M., Ramos, C., Barrios, R. J., & Pérez-Tamayo, R. (1989) · Experimental and Molecular Pathology · doi:10.1016/0014-4800(89)90027-0 · Cited by 25
Oxygen metabolite detoxifying enzyme levels in bleomycin-induced fibrotic lungs
Fantone, J. C., & Phan, S. H. (1988) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(88)90091-3 · Cited by 25
Day, R. M., Suzuki, Y., Lum, J. M., White, A. C., & Fanburg, B. L. (2002) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00338.2001 · Cited by 22
Cited by
Role of nrf2 in oxidative stress and toxicity
Ma, Q. (2013) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011112-140320 · Cited by 4,903
Cell Survival Responses to Environmental Stresses Via the Keap1-Nrf2-ARE Pathway
Kensler, T. W., Wakabayashi, N., & Biswal, S. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.46.120604.141046 · Cited by 3,630
The KEAP1-NRF2 system: a thiol-based sensor-effector apparatus for maintaining redox homeostasis
Yamamoto, M., Kensler, T. W., & Motohashi, H. (2018) · Physiological Reviews · doi:10.1152/physrev.00023.2017 · Cited by 1,968
Self-citationNrf2 signaling pathway: pivotal roles in inflammation
Ahmed, S. M. U., Luo, L., Namani, A., Wang, X. J., & Tang, X. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.11.005 · Cited by 1,794
Mechanistic Studies of the Nrf2-Keap1 Signaling Pathway
Zhang, D. D. (2006) · Drug Metabolism Reviews · doi:10.1080/03602530600971974 · Cited by 1,086
Metadata
- Authors
- Cho, H.-Y., Reddy, S. P. M., Yamamoto, M., & Kleeberger, S. R.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2004-06-18
- Volume
- 18
- Issue
- 11
- Pages
- 1258-1260
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2151012390
- Cited by
- 355
- References
- 42
- FWCI
- 10.93
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.